Table 3. Univariate and multivariate analyses of overall survival in breast cancer patients.
| Parameters | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P value | HR | 95%CI | P value | |
| Age | 1.91 | 1.39–2.63 | 0 | 2.16 | 1.36–3.45 | 0.0013 |
| Histological type | 0.93 | 0.74–1.17 | 0.543 | |||
| Molecular subtype | 1.01 | 0.88–1.16 | 0.901 | |||
| ER | 0.85 | 0.71–1.02 | 0.074 | |||
| PR | 0.87 | 0.73–1.03 | 0.096 | |||
| HER-2 | 1.29 | 1.05–1.57 | 0.013 | 1.12 | 0.90–1.40 | 0.297 |
| Menopause status | 1.16 | 0.94–1.43 | 0.165 | |||
| Stage | 1.64 | 1.40–1.91 | 0 | 2.20 | 1.67–2.91 | 0.0000 |
| Margin status | 1.42 | 1.11–1.81 | 0.005 | 1.03 | 0.74–1.43 | 0.8795 |
| Lymph node status | 1.10 | 0.93–1.30 | 0.274 | |||
| CCBL2 | 2.12 | 1.53–2.93 | 0 | 2.18 | 1.37–3.47 | 0.0011 |
Abbreviations: HR Hazard Ratio, CI confidence interval, bold values of P < 0.05 indicate statistically significant correlations